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DOES ALBUMIN REGULATE ALBUMIN? 
Pietrangelo A, Panduro A. R0.y Chowdhury JR, Shafritz 
DA. Albumin gene expression is down-regulated by 
albumin or macromolecule infusion in the rat. J Clin 
Invest 1992;89: 1755-1760 
ABSTRACT 
A novel feedback regulatory mechanism operating 
on transcription of the albumin gene is described in the 
rat. In 1946, it was proposed that circulating colloids, 
including serum albumin, may affect the synthesis 
and/or secretion of albumin in the liver. The molecular 
basis for this proposed regulation has now been inves- 
tigated by adding oncotically active macromolecules to 
the circulation of normal or genetically albumin- 
deficient Nagase analbuminemic rats (NAR) and ana- 
lyzing the hepatic expression of genes, including al- 
bumin after 24 h. The transcription rate of the albumin 
gene was higher in NAR than in normal rats and was 
dramatically reduced by raising serum albumin to 1.6 
g/dl. Intravenous infusion of albumin into normal rats 
also decreased transcriptional activity of the albumin 
gene by 50-60%, and this decrease correlated with 
changes in serum colloid osmotic pressure after al- 
bumin infusion. Inhibition of albumin gene tran- 
scription was also observed upon intravenous infusion 
of other protein or nonprotein macromolecules, such 
as y-globulin and dextran. This down-regulation ap- 
pears to control the steady-state level of albumin 
mRNA in the liver. Aside from a concomitant decrease 
in apo E gene transcription after albumin or mac- 
romolecule infusion, there was no change in the 
transcription rate of other genes, including those 
exhibiting liver-preferred or -specific expression 
(e.g., tyrosine aminotransferase, cytochrome P-450, 
a,-antitrypsin, apolipoproteins A-I and B, and trans- 
ferrin) or general cellular expression (e.g., a-tubulin, 
pro a, collagen, and fl-actin). Feedback regulation of 
albumin gene expression by serum colloids may serve 
as a specific homeostatic mechanism to maintain the 
steady-state level of total protein in the circulation. 
COMMENTS 
Several decades ago, it was noted that an infusion of 
dextran or an elevation in y-globulins, such as that 
which developed after an immunization, resulted in 
hypoalbuminemia ( 1, 2 ). These clinical observations 
formed the basis for the proposal that colloid osmotic 
pressure, rather than serum albumin levels, regulated 
the synthetic rate of albumin (3). This proposal was then 
tested with a series of experiments performed in rabbits 
and isolated perfused rat livers. Dextran infusions (3) or 
hypergammaglobulinemia (4) in rabbits caused a de- 
crease in the plasma albumin concentration with a shift, 
in the dextran model, of intravascular albumin into the 
extravascular compartment. In addition, the total al- 
bumin pool (i.e., the albumin present in both the 
intravascular and extravascular compartments) de- 
creased despite a lower rate of degradation of albumin. 
The decrease in pool size was thus proposed to be 
secondary to a decrease in albumin synthesis (3, 4). 
Therefore in these experiments the data suggested that 
the regulation of the rate of albumin synthesis was 
independent of the plasma albumin concentration and 
the total albumin pool size. Instead, the rate of albumin 
synthesis may have been regulated by a mechanism 
common to both experimental manipulations. Because 
both dextran and y-globulin are similar in that they are 
macromolecules capable of altering colloid osmotic 
pressure, this supported the proposal that albumin 
synthesis was regulated by colloid osmotic pressure. 
Changing the colloid osmotic pressure in the intact 
animal could potentially cause a series of events (intra- 
hepatic, extrahepatic or both) that would result in the 
alteration of the albumin synthetic rate. The isolated 
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perfused rat liver model was tested to determine 
whether the liver was directly responsive to the changes 
in colloid osmotic pressure or whether extrahepatic 
signals were involved. The results obtained with this 
model were similar to those obtained in intact animals 
(5 ) .  When livers were perfused with blood that was low 
in protein (after plasmapheresis), the rate of albumin 
synthesis doubled. In contrast, when the colloid osmotic 
pressure of the low-protein blood was restored to a level 
equivalent to that of plasma using dextran, albumin 
synthesis was similar to that of controls. In this model, 
the albumin synthetic rate was manipulated despite 
consistently low blood albumin levels by altering the 
content of colloid in the blood, thus providing further 
support for the proposal that colloid osmotic pressure 
regulated the synthetic rate of albumin. 
The term “albumin synthesis” used thus far includes 
all steps necessary for the production and secretion of 
albumin into either the blood or the extravascular 
compartment. The molecular mechanisms (i.e., tran- 
scription, posttranscriptional processing, translation, 
storage or secretion) responsible for the alterations in 
the rate of albumin synthesis that may be secondary to 
changes in colloid osmotic pressure are unknown. 
Pietrangelo and colleagues used an in uiuo molecular 
approach in the rat to test the hypothesis that colloid 
infusions altered the rate of albumin synthesis and 
further define the molecular mechanism(s) responsible 
for the observed alteration in synthetic rate. Three 
different macromolecules were administered to either 
Sprague-Dawley rats (SDR) or Nagase analbuminemic 
rats (NAR). The NAR are a line of rats established from 
SDR in which the analbuminemia is inherited as an 
autosomal recessive trait (6).  NAR have similar levels of 
total protein and slightly lower levels of colloid osmotic 
pressure compared with SDR, but NAR albumin levels 
are approximately 1/1000 that of SDR. Initially, serum 
colloid osmotic pressure was measured in both types of 
rats at baseline and at 2 and 24 hr after an albumin 
infusion. Colloid osmotic pressure increased to a similar 
degree in both types of rats after the albumin infusion. 
The basal transcriptional activity of the albumin gene 
was then evaluated and was found to be twice as high in 
NAR as compared with SDR. Twenty-four hours after 
the infusion of either albumin, dextran or y-globulin, the 
relative transcription rate of several genes expressed in 
the liver was determined. The genes tested included the 
liver-specific genes (albumin, fibrinogen, tyrosine ami- 
notransferase and a,-antitrypsin), the liver-enriched 
genes (apoproteins B and AI and transferrin), the 
broadly expressed genes (p-actin, a-tubulin and az- 
collagen) and the acute-phase reactant genes (fibrinogen 
and a,-acid glycoprotein). Control animals were infused 
with crystalloid (normal saline) rather than colloid. The 
albumin infusions inhibited the relative rate of tran- 
scription of the albumin gene by 50% to 60% in both the 
SDR and the NAR as assessed by densitometric analysis. 
The relative transcription rates of the other genes were 
not altered. The results obtained after the dextran and 
y-globulin infusions were similar to those obtained with 
albumin. The levels of albumin messenger RNA de- 
creased after albumin and dextran infusion, paralleling 
that of transcription. This study nicely demonstrated 
that the changes in the rate of albumin synthesis in 
response to macromolecule infusions was secondary, at 
least in part, to a decrease in the relative rate of 
transcription of the albumin gene. The change in 
transcriptional activity was also reflected in the quantity 
of albumin messenger RNA detected, as assessed by 
Northern-blot analysis. Further studies will be nec- 
essary to explain whether the colloid osmotic pressure 
directly regulates the changes in albumin synthesis. It 
will also be of interest to determine the regulatory 
factors or signals responsible for the changes observed in 
the relative rate of transcription of the albumin gene. 
In addition to providing new insight into the mo- 
lecular mechanisms that are responsible for the physio- 
logical regulation of albumin gene expression in uiuo, the 
article also serves as an important reminder that serum 
albumin levels do not reflect hepatic synthetic function. 
In the studies presented above, in both the rabbit and 
the rat, the concentration of serum albumin was manip- 
ulated by infusing macromolecules, by altering the 
colloid osmotic pressure or both. A potentially similar 
example in human beings may be observed in patients 
who have hypoalbuminemia and hypergammaglobu- 
linemia secondary to chronic liver disease. Clinically, the 
low serum albumin has been interpreted as representing 
altered or damaged hepatic albumin production. Several 
studies have revealed that this interpretation may not be 
correct. When the intravascular albumin pool was eval- 
uated in patients with cirrhosis and hypoalbuminemia, 
the results obtained were variable and many patients fell 
within the normal range (7). In those patients with cir- 
rhosis, hypoalbuminemia and ascites, measurements of 
the total albumin pool were all in the normal range (7). 
Furthermore, the serum proteins and albumin were de- 
pressed, and the globulins were elevated to the same 
levels whether the patients studied synthesized albumin 
at a high or a iow rate (8). The synthetic rate of albumin 
did not correlate with the other conventional “liver 
function tests” or with standard clinical criteria used to 
assess hepatic function (9). Therefore a basic problem 
when evaluating hepatic function in patients is that a 
generally accepted reliable reference value is still 
lacking. The blood liver chemistries and clinical criteria 
used to assess such patients are insufficient to predict 
the course or the prognosis in each individual patient. 
Serum albumin concentration represents the net result 
of synthesis, degradation and distribution (intravas- 
cular and extravascular). It is neither a good index of 
hepatic albumin synthesizing capacity nor the overall 
synthetic capacity of the liver in cirrhosis. Although the 
serum albumin level may be significantly depressed in 
patients with severe liver disease, the rate of albumin 
synthesis may be increased. 
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A D H 1 , Z  AND 3: GENES WHOSE TIMES 
HAVE COME 
van Ooij C, Snyder RC, Paepw BW, Drtester G. Tem- 
poral expression of the human alcohol dehydrogenase 
gene family during liver development correlates with 
differential promoter activation by hepatocyte nuclear 
factor 1, CCAAT/enhancer-binding protein (Y, liver acti- 
vator protein, and D-element-binding protein. Mol Cell 
Biol 1992; 12:3023-303 1. 
ABSTRACT 
The human class I alcohol dehydrogenase (ADH) 
gene family consists of ADHl, ADH2,  and ADH3,  which 
are sequentially activated in early fetal, late fetal, and 
postnatal liver, respectively. Analysis of ADH pro- 
moters revealed differential activation by several 
factors previously shown to control liver transcription. 
In cotransfection assays, the A D H l  promoter, but not 
the A D H 2  or A D H 3  promoter, was shown to respond to 
hepatocyte nuclear factor 1 (HNF-l),  which has previ- 
ously been shown to regulate transcription in early 
liver development. The A D H 2  promoter, but not the 
ADHl or A D H 3  promoter, was shown to respond to 
CCAAT/enhancer-binding protein a (C/EBPa), a tran- 
scription factor particularly active during late fetal 
liver and early postnatal liver development. The A D H l ,  
ADH2,  and A D H 3  promoters all responded to the liver 
transcription factors liver activator protein (LAP) and 
D-element-binding protein (DBP), which are most 
active in postnatal liver. For all three promoters, the 
activation by LAP or DBP was higher than that seen by 
HNF-1 or C/EBPu, and a significant synergism between 
C/EBPa and LAP was noticed for the A D H 2  and A D H 3  
promoters when both factors were simultaneously 
co t rdec ted .  A hierarchy of ADH promoter respon- 
siveness to C/EBPa and LAP homo- and heterodimers is 
suggested. In all three ADH genes, LAP bound to the 
same four sites previously reported for C/EBPa (i.e., 
- 160, - 120, - 40, and - 20 bp), but DBP boundstrongly 
only to the site located at -40 bp relative to the 
transcriptional start. Mutational analysis of ADH2 
indicated that the - 40 bp element accounts for most of 
the promoter regulation by the bZIP factors analyzed. 
These studies suggest that HNF-1 and C/EBPa help 
establish ADH gene family transcription in fetal liver 
and that LAP and DBP help maintain high-level ADH 
gene family transcription in postnatal liver. 
COMMENTS 
A major problem in biologcal studies is to understand 
how genes are switched on and off during development 
and how certain genes remain active at  high levels in 
adult tissues. Broadly speaking, these processes depend 
on the nucleotide sequence of gene promoters (cis-acting 
elements) and protein transcription factors (trans- 
acting factors). The liver has been an attractive model to 
study these questions because of its size, accessibility 
and the large number of well-characterized, abundant 
proteins (mainly enzymes and plasma proteins) that are 
made predominantly in the liver. Studies on the pro- 
moters for the albumin, CY ,-antitrypsin, fibrinogen, 
('-reactive protein and now alcohol dehydrogenase genes 
have revealed a number of transcription factors involved 
in their expression (Table 1). 
CCAATienhancer binding protein (CIEBP) is named 
for its binding to the CCAAT sequence motif and certain 
viral enhancer sequences, and several numbers of this 
family have been identified. These include C/EBPa ( 11, 
liver activator protein (LAP or CIEBPP) (2),  C/EBPy (or 
Igi'EBP-1) [ 3 ) ,  CIEBPG ( 4 ) ,  CRPl and CRP3 (C/EBP- 
related proteins 1 and 3 )  (5).  These factors have been 
designated bZIP proteins because of their basic DNA 
binding region and their "leucine zipper" (a region in 
which leucine occurs as every seventh residue), which 
allows the protein to homodimerize and to het- 
erodimerize with other members of this family of 
proteins 14,5 1. Outside of these two domains, the factors 
are not very homologous. A related protein, D-binding 
protein (DBP), is named for its ability to bind to the D 
region of the albumin promoter ( 6 ) .  It is a bZIP protein 
with a degenerate leucine zipper that will not het- 
erodimerize with other leucine zipper proteins, such as 
C/EBPa or p. Interestingly, an inhibitory factor, liver 
inhibitory protein (LIP),  is translated from the same 
messenger RNA (mRNA) as LAP, using a downstream 
AUG as the initiator codon. LIP binds DNA at the same 
site as LAP (perhaps with higher affinity) but does not 
activate transcription. The ratio of W L I P  may play a 
role in controlling transcription of certain genes, and 
this ratio rises sharply immediately prenatally (7). The 
bZIP factors are encoded by genes having no or few 
introns and are also expressed at lower levels in adipose 
tissue and lung. Of interest, the CiEBPp proteins were 
first identified as participants in the response of acute- 
phase reactant genes to interleukin-1 and interleukin-6 
( 8 ) .  
Another major liver-specific transcription factor is 
hepatocyte nuclear factor-ltu ( HNF-la).  This protein 
